Katti peptides are a class of peptides comprising trimeric amino acids, designed to mimic the three-dimensional morphology of various cellular and protein structures in living organisms. They are named after Professor Kattesh V. Katti, a pioneer in nanomedicine and green nanotechnology, and are used to enhance the delivery and efficacy of therapeutic agents in biomedical and nanoceutical applications.

Katti peptides are synthesized using both synthetic and naturally derived amino acids. They are engineered in three-dimensional frameworks to enhance stability, target specificity, and functional properties. The design incorporates sequences that target specific receptors or tissues and modifications to enhance stability and resistance to proteolytic degradation.

The uniqueness of Katti peptides lies in their three-dimensional trimeric amino acid structures, which mimic cellular and protein morphologies. This structural design allows for targeted therapeutic effects and improved delivery mechanisms, enhancing the efficacy and specificity of therapeutic agents.

Katti peptides are designed for targeted delivery, cell penetration, and therapeutic activity. They can bind specific receptors or tissues, facilitate the delivery of drugs or genetic material into cells, and possess inherent biological activities such as antimicrobial, anti-inflammatory, or anticancer effects.

Katti peptides enhance drug delivery by improving the ability to cross biological barriers, such as the blood-brain barrier, and by being conjugated to nanoparticles for targeted and sustained release of therapeutic agents. This targeted delivery increases the efficacy of treatments and reduces off-target effects.